Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Astragalus Membranaceus for Brain Edema in Hemorrhagic Stroke
NCT01428401Phase 2Completed
- Sponsor
- China Medical University Hospital
- Start
- Jan 2008
- Primary completion
- Dec 2010
- Modality
- HM (Herbal Medicine)
01
Overview
Phase 2, randomised, double-blind trial of astragalus membranaceus in hemorrhagic stroke (2 arms), sponsored by China Medical University Hospital. Primary endpoints: Barthel Index at Week 12, Functional Independence Measure at Week 12 and 2 more. Started Jan 2008; status: completed.
02
Drugs
astragalus membranaceus
03
Conditions
hemorrhagic stroke
Beyond the preview
Go deeper on NCT01428401.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01428401.